Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries.

PubWeight™: 1.97‹?› | Rank: Top 2%

🔗 View Article (PMC 2810888)

Published in Epidemiol Infect on February 01, 2000

Authors

Y Yamaoka1, M S Osato, A R Sepulveda, O Gutierrez, N Figura, J G Kim, T Kodama, K Kashima, D Y Graham

Author Affiliations

1: VA Medical Center and Baylor College of Medicine, Houston, TX 77030, USA.

Articles citing this

Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A (2002) 3.50

Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol (2010) 2.56

Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med (2008) 1.62

Transposable element ISHp608 of Helicobacter pylori: nonrandom geographic distribution, functional organization, and insertion specificity. J Bacteriol (2002) 1.60

Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol (2011) 1.44

Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol Cell Biol (2006) 1.43

Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol (2011) 1.37

Helicobacter acinonychis: genetic and rodent infection studies of a Helicobacter pylori-like gastric pathogen of cheetahs and other big cats. J Bacteriol (2004) 1.35

A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS One (2009) 1.34

Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother (2002) 1.27

Consensus and variable region PCR analysis of Helicobacter pylori 3' region of cagA gene in isolates from individuals with or without peptic ulcer. J Clin Microbiol (2001) 1.22

Pathogenesis of Helicobacter pylori-Related Gastroduodenal Diseases from Molecular Epidemiological Studies. Gastroenterol Res Pract (2012) 1.17

Conservation of the cag pathogenicity island is associated with vacA alleles and gastroduodenal disease in South African Helicobacter pylori isolates. Gut (2001) 1.13

Helicobacter pylori typing as a tool for tracking human migration. Clin Microbiol Infect (2009) 1.12

Attenuated CagA oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon. J Biol Chem (2011) 1.06

Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol (2010) 1.02

Helicobacter pylori CagA protein polymorphisms and their lack of association with pathogenesis. World J Gastroenterol (2010) 0.99

T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (2005) 0.98

Helicobacter pylori virulence factor genotypes in children in the United States: clues about genotype and outcome relationships. J Clin Microbiol (2010) 0.97

Analysis of 3'-end variable region of the cagA gene in Helicobacter pylori isolated from Iranian population. J Gastroenterol Hepatol (2009) 0.97

Intact long-type dupA as a marker for gastroduodenal diseases in Okinawan subpopulation, Japan. Helicobacter (2012) 0.97

Sequence organization and insertion specificity of the novel chimeric ISHp609 transposable element of Helicobacter pylori. J Bacteriol (2004) 0.96

Analysis of virulence factors of Helicobacter pylori isolated from a Vietnamese population. BMC Microbiol (2009) 0.94

Characterization of Helicobacter pylori cagA and vacA genotypes among Alaskans and their correlation with clinical disease. J Clin Microbiol (2011) 0.94

Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection. J Clin Microbiol (2003) 0.94

Helicobacter pylori cagA status and peptic ulcer disease in Iran. Dig Dis Sci (2008) 0.92

Helicobacter pylori cagA gene variants in Malaysians of different ethnicity. Eur J Clin Microbiol Infect Dis (2009) 0.91

Paediatric T-cell lymphoma of the appendix: a case report. Diagn Pathol (2013) 0.90

Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease. Gut Microbes (2013) 0.89

Toll-like Receptor 10 in Helicobacter pylori Infection. J Infect Dis (2015) 0.88

Antibiotic resistance and cagA gene correlation: a looming crisis of Helicobacter pylori. World J Gastroenterol (2012) 0.87

Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. J Gastroenterol Hepatol (2014) 0.86

Association between Helicobacter pylori cagA-related genes and clinical outcomes in Colombia and Japan. BMC Gastroenterol (2011) 0.85

Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions. World J Gastroenterol (2015) 0.83

Prevalence and correlation with clinical diseases of Helicobacter pylori cagA and vacA genotype among gastric patients from Northeast China. Biomed Res Int (2014) 0.83

Prevalence of two homologous genes encoding glycosyltransferases of Helicobacter pylori in the United States and Japan. J Gastroenterol Hepatol (2011) 0.83

Evaluation of the anti-East Asian CagA-specific antibody for CagA phenotyping. Clin Vaccine Immunol (2009) 0.83

Virulence genes of Helicobacter pylori in the Dominican Republic. J Med Microbiol (2014) 0.81

Clarifications regarding the 3' repeat region of the cagA gene in Helicobacter pylori and clinical outcome. J Clin Microbiol (2001) 0.80

A new subtype of 3' region of cagA gene in Helicobacter pylori strains isolated from Zhejiang Province in China. World J Gastroenterol (2004) 0.80

Seroprevalence of Helicobacter pylori in female Vietnamese immigrants to Korea. World J Gastroenterol (2012) 0.80

Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. World J Gastroenterol (2014) 0.79

Is Helicobacter pylori Infection the Primary Cause of Duodenal Ulceration or a Secondary Factor? A Review of the Evidence. Gastroenterol Res Pract (2013) 0.78

The effect of Helicobacter pylori infection on iron stores and iron deficiency in urban Alaska Native adults. Helicobacter (2013) 0.78

Helicobacter pylori cagA 12-bp insertion can be a marker for duodenal ulcer in Okinawa, Japan. J Gastroenterol Hepatol (2013) 0.77

Autophagy-related genes in Helicobacter pylori infection. Helicobacter (2017) 0.75

CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer. J Clin Pathol (2005) 0.75

Rare Helicobacter pylori Virulence Genotypes in Bhutan. Sci Rep (2016) 0.75

Helicobacter pylori from gastric cancer and duodenal ulcer show same phylogeographic origin in the Andean region in Colombia. PLoS One (2014) 0.75

Interleukin-17C in human Helicobacter pylori gastritis. Infect Immun (2017) 0.75

Articles by these authors

Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A (1993) 11.85

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 9.77

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35

Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science (1990) 8.07

Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int (2007) 6.35

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01

Norwalk virus genome cloning and characterization. Science (1990) 5.83

Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science (1995) 5.73

Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun (1995) 5.73

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature (1997) 5.55

Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia (1996) 5.06

Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02

Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature (1994) 5.00

Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87

In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25

Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13

Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology (1998) 4.12

PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254. Cell (1991) 3.95

Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol (1992) 3.82

A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66

A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A (2000) 3.66

Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates. Int J Cancer (1988) 3.60

Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol (1996) 3.57

CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol (1994) 3.48

Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut (1997) 3.39

The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33

Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol (1996) 3.32

Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31

Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol (1996) 3.20

Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J Virol (1992) 3.16

N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun (1988) 3.16

Vaccine protection against simian immunodeficiency virus infection. Proc Natl Acad Sci U S A (1989) 3.13

Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet (1991) 3.09

Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology (1996) 3.00

Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol (1993) 2.96

Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95

Prevalence, species differentiation, and toxigenicity of Aeromonas strains in cases of childhood gastroenteritis and in controls. J Clin Microbiol (1986) 2.88

Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology (1992) 2.83

The initial phosphate burst in ATP hydrolysis by myosin and subfragment-1 as studied by a modified malachite green method for determination of inorganic phosphate. J Biochem (1986) 2.83

Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat Genet (1999) 2.81

Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Proc Natl Acad Sci U S A (1996) 2.69

Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J Biol Chem (1996) 2.67

Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells. J Virol (1982) 2.67

A plaque assay for the simian rotavirus SAII. J Gen Virol (1979) 2.65

A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1997) 2.63

Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori. J Clin Pathol (1992) 2.60

Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology (1982) 2.60

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology (1999) 2.54

Desulfurization of dibenzothiophene by Corynebacterium sp. strain SY1. Appl Environ Microbiol (1992) 2.51

Rotavirus stability and inactivation. J Gen Virol (1979) 2.48

Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother (1997) 2.47

Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med (1994) 2.47

Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology (1999) 2.44

Patients, payers, and paradigm shifts: what to do about Helicobacter pylori. Am J Gastroenterol (1996) 2.43

Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature (1990) 2.40

Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter (1998) 2.39

Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis (1998) 2.38

Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol (1997) 2.37

Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc (1994) 2.36

Protection from lethal gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. J Exp Med (2000) 2.32

The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J Exp Med (1999) 2.32

Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med (1984) 2.29

The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med (1997) 2.28

Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells. Mol Microbiol (1993) 2.24

Biotin-containing intranuclear inclusions in endometrial glands during gestation and puerperium. Am J Clin Pathol (1993) 2.21

Isolation and characterization of simian immunodeficiency virus from mandrills in Africa and its relationship to other human and simian immunodeficiency viruses. J Virol (1988) 2.17

Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol (1994) 2.16

A Bacillus subtilis gene-encoding protein homologous to eukaryotic SMC motor protein is necessary for chromosome partition. Mol Microbiol (1998) 2.15

Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut (1994) 2.14

Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun (1999) 2.14

Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol (1996) 2.14

Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis. Genomics (2000) 2.14

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13

Expression of cytokine mRNA in gastric mucosa with Helicobacter pylori infection. Scand J Gastroenterol (1995) 2.12

Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler Thromb Vasc Biol (2000) 2.12

Pancreatic-biliary ascariasis: experience of 300 cases. Am J Gastroenterol (1997) 2.10

Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. J Exp Med (1999) 2.08